Follow
Fida K. Dankar
Title
Cited by
Cited by
Year
Protecting privacy using k-anonymity
K El Emam, FK Dankar
Journal of the American Medical Informatics Association 15 (5), 627-637, 2008
4412008
A globally optimal k-anonymity method for the de-identification of health data
K El Emam, FK Dankar, R Issa, E Jonker, D Amyot, E Cogo, JP Corriveau, ...
Journal of the American Medical Informatics Association 16 (5), 670-682, 2009
3412009
Practicing differential privacy in health care: A review.
FK Dankar, K El Emam
Trans. Data Priv. 6 (1), 35-67, 2013
2052013
The application of differential privacy to health data
FK Dankar, K El Emam
Proceedings of the 2012 Joint EDBT/ICDT Workshops, 158-166, 2012
1442012
Informed consent in biomedical research
FK Dankar, M Gergely, SK Dankar
Computational and structural biotechnology journal 17, 463-474, 2019
1202019
Estimating the re-identification risk of clinical data sets
FK Dankar, K El Emam, A Neisa, T Roffey
BMC medical informatics and decision making 12, 1-15, 2012
1122012
Fake it till you make it: Guidelines for effective synthetic data generation
FK Dankar, M Ibrahim
Applied Sciences 11 (5), 2158, 2021
842021
Evaluating the risk of re-identification of patients from hospital prescription records
K El Emam, FK Dankar, R Vaillancourt, T Roffey, M Lysyk
The Canadian journal of hospital pharmacy 62 (4), 307, 2009
702009
Re-identification risk in de-identified databases containing personal information
K El Emam, F Dankar
US Patent 8,316,054, 2012
632012
A multi-dimensional evaluation of synthetic data generators
FK Dankar, MK Ibrahim, L Ismail
IEEE Access 10, 11147-11158, 2022
582022
Dynamic-informed consent: A potential solution for ethical dilemmas in population sequencing initiatives
FK Dankar, M Gergely, B Malin, R Badji, SK Dankar, K Shuaib
Computational and structural biotechnology journal 18, 913-921, 2020
582020
The development of large-scale de-identified biomedical databases in the age of genomics—principles and challenges
FK Dankar, A Ptitsyn, SK Dankar
Human genomics 12, 1-15, 2018
502018
A method for evaluating marketer re-identification risk
FK Dankar, K El Emam
Proceedings of the 2010 EDBT/ICDT Workshops, 1-10, 2010
502010
System and method for optimizing the de-identification of data sets
K El Emam, I Romeo, F Dankar
US Patent 8,326,849, 2012
492012
Evaluating the risk of patient re-identification from adverse drug event reports
K El Emam, FK Dankar, A Neisa, E Jonker
BMC medical informatics and decision making 13, 1-14, 2013
392013
De-identifying a public use microdata file from the Canadian national discharge abstract database
KE Emam, D Paton, F Dankar, G Koru
BMC medical informatics and decision making 11, 1-26, 2011
332011
A protocol for the secure linking of registries for HPV surveillance
K El Emam, S Samet, J Hu, L Peyton, C Earle, GC Jayaraman, T Wong, ...
PLoS One 7 (7), e39915, 2012
322012
Privacy-preserving analysis of distributed biomedical data: designing efficient and secure multiparty computations using distributed statistical learning theory
FK Dankar, N Madathil, SK Dankar, S Boughorbel
JMIR medical informatics 7 (2), e12702, 2019
312019
Evaluating the Risk of Re-identification of Patients from Hospital Prescription Records.
KE Emam, FK Dankar, R Vaillancourt, T Roffey, M Lysyk
The Canadian Journal of Hospital Pharmacy 62 (4), 307-319, 2009
292009
A risk-based framework for biomedical data sharing
F Dankar, R Badji
journal of biomedical informatics 66, 231-240, 2017
262017
The system can't perform the operation now. Try again later.
Articles 1–20